EWA
FOLD

EverSource Wealth Advisors’s Amicus Therapeutics FOLD Stock Holding History

EverSource Wealth Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,700
Closed -$39K – 4452
2026
Q1 		$39K Sell
2,700
-3,096
-53% -$44.4K ﹤0.01% 2074
2025
Q4 		$82.5K Sell
5,796
-2,520
-30% -$24.8K ﹤0.01% 1417
2025
Q3 		$65.5K Buy
8,316
+3,861
+87% +$27.5K ﹤0.01% 1511
2025
Q2 		$25.5K Buy
4,455
+3,677
+473% +$23.7K ﹤0.01% 2104
2025
Q1 		$6.35K Sell
778
-416
-35% -$3.85K ﹤0.01% 2377
2024
Q4 		$11.2K Buy
1,194
+595
+99% +$6.18K ﹤0.01% 1925
2024
Q3 		$6.4K Buy
599
+525
+709% +$5.72K ﹤0.01% 2115
2024
Q2 		$763 Buy
74
+17
+30% +$175 ﹤0.01% 2793
2024
Q1 		$570 Buy
+57
New +$729 ﹤0.01% 2683

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

EverSource Wealth Advisors's FOLD Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 2,700 shares — an estimated $39K sold.

EverSource Wealth Advisors first reported a position in FOLD in Q1 2024 and held it in 9 quarters. The position peaked at $82.5K in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • EverSource Wealth Advisors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • EverSource Wealth Advisors sold 2,700 Amicus Therapeutics shares in Q2 2026, an estimated $39K.
  • EverSource Wealth Advisors first reported a position in Amicus Therapeutics in Q1 2024 and held it in 9 quarters.
  • EverSource Wealth Advisors's Amicus Therapeutics position peaked at $82.5K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.